Insights from leading international and Australian experts in ophthalmology.
Brolucizumab Update-Presented by Dr Sophia Zagora
Please join Retinal and Uveitis specialist Dr Sophia Zagora as she takes the viewer through the journey of brolucizumab to date including an update on post marketing surveillance of Brolucizumab since the USA launch in October 2019.
Vision: Real world perspectives
International ophthalmology expert Prof. Frank Holz discusses safety insights, real world experience with Beovu and treatment for wet AMD.
Beovu Treatment Journey
Overall, how does Beovu® (brolucizumab) change the treatment journey for wet AMD paitents and their caregivers?
When do you consider switching your patients to Beovu® (brolucizumab)?
Beovu and other aVEGFs
What differentiates Beovu® (brolucizumab) from existing anti-VEGFs?
What key points do you disucss with your patients when counselling them on starting treatment with Beovu® (brolucizumab)?